Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05821660Not ApplicableCompleted

Fastreset Study: Metabolic Effects of a Five-day Remotely Delivered Hypocaloric and Ketogenic Program

Role: lead

NCT07155993Enrolling By Invitation

FastForward: A Prospective Analysis of Long-term Fasting and Subsequent Food Reintroduction in Humans

Role: lead

NCT05031598Not ApplicableCompleted

Long-term Fasting: Multi-system Adaptations in Humans

Role: lead

NCT05449249Not ApplicableCompleted

Oral and Gut Microbiota Changes During Long-term Fasting in Humans

Role: lead

All 4 trials loaded